The Chemours Company Financial Statements (CC)
|
|
Report date
|
|
|
12.02.2021 |
11.02.2022 |
30.06.2022 |
10.02.2023 |
27.03.2024 |
|
04.11.2024 |
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
4 969 |
6 345 |
0.000 |
6 794 |
6 027 |
|
5 750 |
Operating Income, bln rub |
|
|
509.0 |
888.0 |
0.000 |
913.0 |
-92.0 |
|
375.0 |
EBITDA, bln rub |
? |
|
767.0 |
1 205 |
0.000 |
1 204 |
197.0 |
|
571.0 |
Net profit, bln rub |
? |
|
219.0 |
608.0 |
815.0 |
578.0 |
-238.0 |
|
69.0 |
|
OCF, bln rub |
? |
|
807.0 |
820.0 |
|
754.0 |
556.0 |
|
-287.0 |
CAPEX, bln rub |
? |
|
267.0 |
277.0 |
|
307.0 |
370.0 |
|
386.0 |
FCF, bln rub |
? |
|
540.0 |
543.0 |
|
447.0 |
186.0 |
|
-673.0 |
Dividend payout, bln rub
|
|
|
164.0 |
164.0 |
|
154.0 |
149.0 |
|
149.0 |
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
Dividend payout ratio, %
|
|
|
74.9% |
27.0% |
0.00% |
26.6% |
0.00% |
|
215.9% |
|
OPEX, bln rub |
|
|
620.0 |
699.0 |
0.000 |
828.0 |
1 398 |
|
752.0 |
Cost of production, bln rub |
|
|
3 902 |
4 964 |
0.000 |
5 178 |
4 721 |
|
4 627 |
R&D, bln rub |
|
|
93.0 |
107.0 |
0.000 |
118.0 |
108.0 |
|
109.0 |
Interest expenses, bln rub |
|
|
210.0 |
185.0 |
170.0 |
163.0 |
208.0 |
|
261.0 |
|
Assets, bln rub |
|
|
7 082 |
7 550 |
7 730 |
7 640 |
8 251 |
|
7 463 |
Net Assets, bln rub |
? |
|
813.0 |
1 081 |
1 214 |
1 107 |
737.0 |
|
657.0 |
Debt, bln rub |
|
|
4 277 |
3 928 |
3 858 |
3 813 |
4 299 |
|
4 290 |
Cash, bln rub |
|
|
1 105 |
1 451 |
1 248 |
1 102 |
1 203 |
|
596.0 |
Net debt, bln rub |
|
|
3 172 |
2 477 |
2 610 |
2 711 |
3 096 |
|
3 694 |
|
Ordinary share price, rub |
|
|
24.8 |
33.6 |
32.0 |
30.6 |
31.5 |
|
24.5 |
Number of ordinary shares, mln |
|
|
164.7 |
164.9 |
156.6 |
155.4 |
148.9 |
|
149.7 |
|
Market cap, bln rub |
|
|
4 082 |
5 536 |
5 014 |
4 757 |
4 697 |
|
3 660 |
EV, bln rub |
? |
|
7 254 |
8 013 |
7 624 |
7 468 |
7 793 |
|
7 354 |
Book value, bln rub |
|
|
646 |
973 |
1 099 |
992 |
632 |
|
608 |
|
EPS, rub |
? |
|
1.33 |
3.69 |
5.20 |
3.72 |
-1.60 |
|
0.46 |
FCF/share, rub |
|
|
3.28 |
3.29 |
0.00 |
2.88 |
1.25 |
|
-4.50 |
BV/share, rub |
|
|
3.92 |
5.90 |
7.02 |
6.39 |
4.24 |
|
4.06 |
|
EBITDA margin, % |
? |
|
15.4% |
19.0% |
|
17.7% |
3.27% |
|
9.93% |
Net margin, % |
? |
|
4.41% |
9.58% |
|
8.51% |
-3.95% |
|
1.20% |
FCF yield, % |
? |
|
13.2% |
9.81% |
0.00% |
9.40% |
3.96% |
|
-18.4% |
ROE, % |
? |
|
26.9% |
56.2% |
67.1% |
52.2% |
-32.3% |
|
10.5% |
ROA, % |
? |
|
3.09% |
8.05% |
10.5% |
7.57% |
-2.88% |
|
0.92% |
|
P/E |
? |
|
18.6 |
9.10 |
6.15 |
8.23 |
-19.7 |
|
53.0 |
P/FCF |
|
|
7.56 |
10.2 |
|
10.6 |
25.3 |
|
-5.44 |
P/S |
? |
|
0.82 |
0.87 |
|
0.70 |
0.78 |
|
0.64 |
P/BV |
? |
|
6.32 |
5.69 |
4.56 |
4.80 |
7.43 |
|
6.02 |
EV/EBITDA |
? |
|
9.46 |
6.65 |
|
6.20 |
39.6 |
|
12.9 |
Debt/EBITDA |
|
|
4.14 |
2.06 |
|
2.25 |
15.7 |
|
6.47 |
|
R&D/CAPEX, % |
|
|
34.8% |
38.6% |
|
38.4% |
29.2% |
|
28.2% |
|
CAPEX/Revenue, % |
|
|
5.37% |
4.37% |
|
4.52% |
6.14% |
|
6.71% |
|
The Chemours Company shareholders |